Published: 16 November 2026
Last updated: 16 November 2026
New research is revealing the importance of genetic connections in the early identification of cancer.
A study published in late October identified inherited cancer-risk variants in approximately one in 10 patients who underwent comprehensive tumour genomic profiling and follow-up genetic testing.
The research has major implications for family members of cancer patients who may be screened and have cancers identified earlier.
Genetic testing for inherited cancer risk is particularly relevant to the Jewish community, where approximately one in 40 people of Ashkenazi Jewish ancestry carries a harmful inherited change in BRCA1 or BRCA2, which can increase the risk of several cancers, including breast, ovarian and prostate cancer.
Not everyone needs genetic testing for cancer, but understanding your family's cancer history can help identify who may be at increased risk, who might benefit from genetic counselling or testing, and who could benefit from earlier or more frequent screening to detect cancer when treatment is more effective.
Family members who learn that they may carry the same harmful genetic change can seek advice about testing and, where appropriate, earlier or more frequent screening.
Within Australia's Jewish community, we should encourage conversations about family cancer history
Importantly, inheriting a risk does not mean a person will inevitably develop cancer, but the knowledge of genetic risk may help detect some cancers at a stage when treatment is more effective.




